Upcoming Episode of Innovations with Ed Begley Jr. to Feature Alzheimer’s Drug Discovery Foundation

Share Article

DMG Productions explores the latest breakthroughs in drug discovery and clinical research.

News Image

Alzheimer’s Drug Discovery Foundation (ADDF), announced today that it will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year. Dates and show times TBA.

The ADDF provides critical seed funding to leading scientists conducting breakthrough drug discovery and clinical research. In this segment, viewers will learn how by accelerating promising drug candidates through the drug development pipeline and spearheading innovative public-private partnerships, the ADDF increases the chance of finding an effective treatment, and a cure, for Alzheimer’s disease.

“We are excited by the opportunity to be a part of Innovations with Ed Begley Jr.” said Howard Fillit, MD, Founding Executive Director and Chief Science Officer for the ADDF. “The ADDF has been a pioneer in funding diverse and novel targets for drug discovery for Alzheimer’s disease. Today, several drugs that we supported through the risky phases of early development are in clinical trials. We look forward to sharing these promising advances that are bringing us closer to effective treatments for Alzheimer’s disease.”

“The ADDF employs a venture philanthropy model to proactively source drug discovery projects in both academia and industry, strategically targeting under-funded areas through an iterative and flexible funding process,” said Michele Nehls, Producer for the Innovations series. “We look forward to educating audiences on the amazing strides they’re making in the medical community.”

About the ADDF:
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. It’s the only venture philanthropic organization solely dedicated to funding the development of drugs for Alzheimer’s. Through the support of its donors, the ADDF has awarded $70 million to fund over 450 Alzheimer’s drug discovery programs and clinical trials in 18 countries. For more information, visit: http://www.alzdiscovery.org.

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Field producers work closely with experts in the field to develop stories. This powerful force enables DMG to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: http://www.InnovationsTelevision.com or contact Michele Nehls at (866) 496-4065 x 822 or via email at Michele(at)InnovationsTelevision.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michele Nehls
DMG Productions
+1 866-496-4065 Ext: 802
Email >
Visit website